You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬泰生物(603392.SH):擬以募集資金向全資子公司萬泰滄海、萬泰凱瑞增資
格隆匯 07-06 18:05

格隆匯 7 月 6日丨萬泰生物(603392.SH)公告,萬泰滄海系北京萬泰生物藥業股份有限公司(以下簡稱“公司”)全資子公司,公司註冊資本為80,000萬元,其中已經到位實收資本為65,000萬元。萬泰滄海為募投項目《宮頸癌疫苗質量體系提升及國際化項目》的實施主體,本次增資計劃投入募集資金總額為15,000萬元。為了保證募集資金投入募投項目,確保募投項目順利推進,公司決定以募集資金向萬泰滄海增資方式投入,並在滄海設立募集資金四方監管賬户,按《募集資金管理辦法》對募集資金專項監管。

萬泰凱瑞系萬泰生物全資子公司,目前公司註冊資本為5,000萬元,其中已經到位實收資本為5,000萬元。萬泰凱瑞為募投項目《化學發光試劑製造系統自動化技術改造及國際化認證項目》實施主體,本次增資計劃投入募集資金總額為15,000萬元。為了保證募集資金投入募投項目,確保募投項目順利推進,公司決定以募集資金向萬泰凱瑞增資方式投入,並在萬泰凱瑞設立募集資金四方監管賬户,按《募集資金管理辦法》對募集資金專項監管。

公司於2020年7月6日召開第四屆董事第十七次會議,審議通過了《關於以募集資金向廈門萬泰滄海生物技術有限公司增資及以募集資金置換自籌資金預先投入募集資金投資項目資金的議案》及《關於以募集資金向廈門萬泰凱瑞生物技術有限公司增資的議案》,同意公司以募集資金向全資子公司萬泰滄海、萬泰凱瑞增資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account